Skip to main content

Table 4 Availability of malaria commodities in the private sector

From: Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies

  Private for-profit health facility Pharmacy Drug store General retailer Itinerant drug vendor All private sector
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Among all screened outlets, availability of N = 668 N = 290 N = 338 N = 23,840 N = 924 N = 26,060
 Any anti-malarial 31.0 (26.1, 36.3) 20.5 (14.8, 27.6) 6.6 (4.2, 10.1) 0.2 (0.1, 0.4) 15.1 (11.4, 19.8) 1.8 (1.5, 2.1)
Among anti-malarial-stocking outlets or outlets stocking anti-malarials in the past 3 months, availability of N = 237 N = 74 N = 34 N = 39 N = 186 N = 570
 Diagnostics
  Any malaria blood testing 83.0 (76.8, 87.8) 70.1 (58.2, 79.7) 60.9 (40.8, 77.9) 0.0 (–) 60.4 (50.6, 69.4) 64.7 (58.5, 70.3)
  Malaria microscopy 15.6 (10.9, 22.0) 4.8 (1.6, 13.1) 4.0 (0.6, 21.7) 0.0 (–) 5.6 (3.2, 9.8) 8.7 (6.4, 11.9)
  RDT 81.3 (74.8, 86.5) 70.1 (58.2, 79.7) 60.9 (40.8, 77.9) 0.0 (–) 59.8 (50.0, 68.9) 63.8 (57.6, 69.6)
Among anti-malarial stocking outlets, availability of N = 186 N = 45 N = 22 N = 29 N = 109 N = 391
Anti-malarials       
  Any first-line ACT 90.0 (82.5, 94.5) 85.6 (74.3, 92.4) 47.9 (27.8, 68.6) 2.8 (0.5, 15.6) 62.8 (51.7, 72.7) 70.9 (63.1, 77.6)
  DHA PPQ 90.0 (82.5, 94.5) 85.6 (74.3, 92.4) 47.9 (27.8, 68.6) 2.8 (0.5, 15.6) 62.8 (51.7, 72.7) 70.9 (63.1, 77.6)
  ASMQ FDC 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–)
  Primaquine 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–)
  Chloroquine 4.6 (2.0, 10.3) 7.7 (2.9, 19.1) 20.5 (9.7, 38.1) 67.1 (27.6, 91.6) 30.7 (20.1, 43.7) 19.7 (14.1, 26.9)
  Other non-artemisinin therapy 1.3 (0.3, 5.4) 0.0 (–) 6.8 (1.9, 21.4) 0.0 (–) 1.8 (0.6, 5.2) 1.5 (0.7, 3.3)
  Oral AMT 0.0 (–) 0.0 (–) 0.0 (–) 2.3 (0.4, 12.7) 0.0 (–) 0.2 (0.0, 1.2)
  IV/IM artesunate 0.0 (–) 0.0 (–) 0.0 (–) 0.0 (–) 0.7 (0.1, 4.0) 0.2 (0.0, 1.3)
  Availability of first-line ACT and malaria blood testing 80.4 (72.6, 86.3) 67.1 (52.5, 79.0) 23.6 (10.0, 46.1) 0.0 (–) 50.8 (40.2, 61.3) 59.4 (51.9, 66.6)
  Availability of first-line ACT, blood testing not available 9.6 (6.1, 15.0) 18.5 (10.5, 30.5) 24.3 (9.4, 49.9) 2.8 (0.5, 15.6) 12.0 (7.0, 19.9) 11.5 (8.4, 15.4)